Picture of Financiere de Tubize SA logo

TUB Financiere de Tubize SA Share Price

0.000.00%
be flag iconLast trade - 00:00
HealthcareBalancedLarge CapMomentum Trap

Momentum

Relative Strength (%)
1m+5.76%
3m+19.9%
6m+20.21%
1yr+10.61%
Volume Change (%)
10d/3m+63.25%
Price vs... (%)
52w High-2.23%
50d MA+6.61%
200d MA+24.19%

Growth & Value

Shareholder Activity

TypeBuy / Hold / Sell
Institutions
Directors
Community

Guru Screens

Quality

NameIndustryMarket
Return on Capital-0.1%
Return on Equity4.97%
Operating Marginn/a

Financial Summary

Health Trend(F-Score)

12345678910

Bankruptcy Score(Z-Score)

Distress
Cautious
Safe

Earnings Manipulation Risk(M-Score)

Other Ratios

Leverage (ttm)Total- Intang+ Pension
Gross Gearing
Net Gearing
Cash / Assets

Recent History

Latest interim period vs. prior periodIndustryMarket
Sales Growth
EPS Growth
3yr Compound Annual Growth RateIndustryMarket
Sales CAGR
EPS CAGR
DPS CAGR

Graphical History

Revenue
Blurred out image of Revenue chart
Net Income
Blurred out image of Net Income chart
Normalised EPS
Blurred out image of Normalised EPS chart
PE Ratio Range
Blurred out image of PE Ratio Range chart
Dividend Yield Range
Blurred out image of Dividend Yield Range chart

Analyst Forecasts

Price target
( price)
31st Dec 202431st Dec 2025
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change

Analyst Consensus

Strong SellSellHoldBuyStrong Buy

EPS 2024 / 2025

Blurred out image of Financiere de Tubize SA EPS forecast chart

Profile Summary

Financiere de Tubize SA is a Belgium-based holding company. The Company holds minor capital in UCB SA. UCB is a Belgian pharmaceutical and specialty chemical company that specializes in two therapeutic areas: diseases of the central nervous system (CNS) and immunology. UCB, together with its subsidiaries, has research and development facilities in Belgium, Germany, Japan, the United Kingdom and the United States. The Company promotes the development of a sustainable biopharma ecosystem in Belgium and possibly in other geographic areas relevant to UCB.

Directors

Last Annual
December 31st, 2023
Last Interim
December 31st, 2023
Incorporated
January 1st, 1928
Public Since
January 2nd, 1987
Sector
Pharmaceuticals
Industry
Healthcare
Exchange
be flag iconEuronext - Brussels
Shares in Issue
44,512,598

TUB Share Price Performance

Upcoming Events for TUB

Dividend For TUB.BR - 0.9700 EUR

Q2 2024 Financiere de Tubize SA Earnings Release

Similar to TUB

Picture of Biosenic SA logo

Biosenic SA

be flag iconEuronext - Brussels

Picture of Fagron NV logo

Fagron NV

be flag iconEuronext - Brussels

Picture of Hyloris Pharmaceuticals SA logo

Hyloris Pharmaceuticals SA

be flag iconEuronext - Brussels

Picture of Mithra Pharmaceuticals SA logo

Mithra Pharmaceuticals SA

be flag iconEuronext - Brussels

Picture of UCB SA logo

UCB SA

be flag iconEuronext - Brussels

FAQ